Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation
According to standard clinical guidance and Omzo's own eligibility framing, licensed clinicians evaluating GLP-1 candidacy typically consider factors like body mass index, medical history, existing conditions (particularly thyroid disease, pancreatitis, or other contraindications for GLP-1 medications), current medications, and personal health goals
Support may include recommendations around nutrition, activity, sleep, and behavioral patterns that influence results
A Certificate of Analysis is available on request for lot-level documentation
The injections utilize a specialized formula that breaks down fat cells in the treated area